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Abigail Mitchell, Danielle Frances, Chase Metzger
Sex Differences in the Disease Progression of FTD vs AD.

Abstract
Neurodegenerative diseases are on the rise in aging populations due to the upper tier of the
population getting larger in that age group (Zheng & Chen, 2022). Knowing this, there is great
benefit in more accurate and early diagnosis of conditions like frontotemporal dementia (FTD)
and Alzheimer’s disease (AD). Particularly, it is important to understand which variables may
contribute to differences in disease burden and progression of associated sequalae, with one of
those variables being biological sex. The current study investigated sex differences in the disease
progression of Frontotemporal dementia (FTD) verses Alzheimer’s (AD) over time. All data for
this study was extracted from open datasets provided by the National Alzheimer’s Coordinating
Center (NACC). Disease progression is quantified by deficits in cognitive ability as well as
volumetric loss in the brain. In particular, voxel-based morphometry analyses on high-resolution
T1 MRI scans extracted whole grey matter volumes (GM) at 2 timepoints, separated by years, as
well as regionally-specific volumetric measures of the insula for FTD, hippocampus for AD and
the cingulate cortex for both conditions. Coping ability outcomes, measured by traditional
clinical assessments at matching timepoints to the MRI acquisitions include the Clinical
Dementia Rating scale sum of boxes (CDRsb), Mini-mental state exam (MMSE), and Montreal
cognitive assessment (MOCA). The current study expects to replicate existing findings in the
field, with FTD and AD female patients revealing faster disease progression than males, as
measure by volumetric analyses. However, it is expected that FTD females will reveal better
coping abilities compared to males, and that AD females will have worse coping abilities in a
similar sex comparison. The data is currently being analyzed and the results will be presented at

the conference. Understanding sex differences is important for clinical considerations in order to
provide more accurate diagnoses and tailor clinical interventions for better clinical outcomes.

